Wird geladen...

Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury

Myocardial ischemia/reperfusion (I/R) injury is a major cause of mortality and morbidity worldwide. Among factors contributing to I/R injury, proteolytic enzymes could also cause cellular injury, expand the injured area and induce inflammation, which then lead to cardiac dysfunction. Therefore, prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biomedicines
Hauptverfasser: Mongkolpathumrat, Podsawee, Kijtawornrat, Anusak, Prompunt, Eakkapote, Panya, Aussara, Chattipakorn, Nipon, Barrère-Lemaire, Stephanie, Kumphune, Sarawut
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8070046/
https://ncbi.nlm.nih.gov/pubmed/33924676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040422
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!